Changmao (Dalian) New Material Company Limited, a wholly-owned subsidiary of Changmao Biochemical Engineering Co. Ltd., has entered into a significant sale and leaseback arrangement. On 30 June 2025, Changmao Dalian and its Lessor signed the Sale and Leaseback Agreements, which involve transferring the Leased Assets to the Lessor. This transaction is part of a major financial initiative by the parent company, aimed at optimizing its asset management strategy. The arrangement includes several agreements, such as a finance lease agreement and an ownership transfer agreement. The parent company, Changmao Biochemical Engineering Co. Ltd., is a joint stock limited company incorporated in the People's Republic of China and is publicly listed on the Main Board of the Stock Exchange of Hong Kong.